Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

3.1K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
3.1K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

7.4K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
7.4K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

6.1K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
6.1K
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

2.0K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
2.0K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

8.6K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
8.6K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

1.3K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pancreatic islet α cell function and proliferation require the arginine transporter SLC7A2.

The Journal of clinical investigation·2026
Same author

Proinsulin regulators identified with CRISPR screen and in vivo mouse QTL mapping.

Nature communications·2026
Same author

Distinct genetic architecture of gene and isoform level QTL in the Diversity Outbred (DO) mouse population.

bioRxiv : the preprint server for biology·2026
Same author

Restriction of Individual Branched-Chain Amino Acids has Distinct Effects on the Development and Progression of Alzheimer's Disease in 3xTg Mice.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Mammals that can develop type 2 diabetes have a similarly structured β-sheet amyloid oligomer.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

A structural model of toxic amyloid oligomers involved in type 2 diabetes.

Proceedings of the National Academy of Sciences of the United States of America·2026

Related Experiment Video

Updated: Apr 3, 2026

Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate
05:58

Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate

Published on: June 25, 2019

8.1K

How do reducing equivalents increase insulin secretion?

Alan D Attie

    The Journal of Clinical Investigation
    |September 22, 2015
    PubMed
    Summary
    This summary is machine-generated.

    Researchers discovered a new pathway that amplifies insulin secretion. This involves cytosolic isocitrate dehydrogenase, generating NADPH and activating SENP1, which is crucial for glucose tolerance and may be a therapeutic target for type 2 diabetes.

    More Related Videos

    Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
    07:30

    Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

    Published on: May 10, 2018

    9.9K
    An In Ovo Model for Testing Insulin-mimetic Compounds
    06:09

    An In Ovo Model for Testing Insulin-mimetic Compounds

    Published on: April 23, 2018

    11.2K

    Related Experiment Videos

    Last Updated: Apr 3, 2026

    Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate
    05:58

    Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate

    Published on: June 25, 2019

    8.1K
    Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
    07:30

    Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

    Published on: May 10, 2018

    9.9K
    An In Ovo Model for Testing Insulin-mimetic Compounds
    06:09

    An In Ovo Model for Testing Insulin-mimetic Compounds

    Published on: April 23, 2018

    11.2K

    Area of Science:

    • Endocrinology
    • Metabolic pathways
    • Cellular signaling

    Background:

    • Insulin secretion from pancreatic beta cells is triggered by glucose, involving cell depolarization and calcium channel activation.
    • Existing models do not fully explain the magnitude of the insulin secretory response.

    Purpose of the Study:

    • To elucidate the mechanisms amplifying glucose-stimulated insulin secretion.
    • To investigate the role of cytosolic isocitrate dehydrogenase and SENP1 in insulin exocytosis.

    Main Methods:

    • Utilized murine models with beta cell-specific deletion of Senp1.
    • Assessed insulin exocytosis and glucose tolerance.
    • Investigated the impact of restoring intracellular NADPH and activating SENP1 in human beta cells.

    Main Results:

    • Cytosolic isocitrate dehydrogenase activity amplifies insulin secretion by generating NADPH and reduced glutathione, activating SENP1.
    • Beta cell-specific deletion of Senp1 impaired insulin exocytosis and glucose tolerance in mice.
    • Restoring NADPH or activating SENP1 improved insulin exocytosis in human type 2 diabetes beta cells.

    Conclusions:

    • Insulin secretion amplification is dependent on the cytosolic isocitrate dehydrogenase-NADPH-SENP1 pathway.
    • SENP1 plays a critical role in regulating glucose tolerance.
    • Targeting the NADPH-SENP1 pathway represents a potential therapeutic strategy for type 2 diabetes.